155 related articles for article (PubMed ID: 12895191)
1. Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects.
Sathirakul K; Chan C; Teng L; Bergstrom RF; Yeo KP; Wise SD
Br J Clin Pharmacol; 2003 Aug; 56(2):184-7. PubMed ID: 12895191
[TBL] [Abstract][Full Text] [Related]
2. Influence of fluoxetine on olanzapine pharmacokinetics.
Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
[TBL] [Abstract][Full Text] [Related]
3. [Monitoring of serum olanzapine during antipsychotic treatment].
Linnet K; Olesen OV
Ugeskr Laeger; 2000 Sep; 162(36):4802-5. PubMed ID: 10994377
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia.
Grothe DR; Calis KA; Jacobsen L; Kumra S; DeVane CL; Rapoport JL; Bergstrom RF; Kurtz DL
J Clin Psychopharmacol; 2000 Apr; 20(2):220-5. PubMed ID: 10770461
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
Hägg S; Spigset O; Lakso HA; Dahlqvist R
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):493-7. PubMed ID: 11699614
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine. Pharmacokinetic and pharmacodynamic profile.
Callaghan JT; Bergstrom RF; Ptak LR; Beasley CM
Clin Pharmacokinet; 1999 Sep; 37(3):177-93. PubMed ID: 10511917
[TBL] [Abstract][Full Text] [Related]
7. Differential olanzapine plasma concentrations by sex in a fixed-dose study.
Kelly DL; Conley RR; Tamminga CA
Schizophr Res; 1999 Nov; 40(2):101-4. PubMed ID: 10593449
[TBL] [Abstract][Full Text] [Related]
8. Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers.
Penzak SR; Hon YY; Lawhorn WD; Shirley KL; Spratlin V; Jann MW
J Clin Psychopharmacol; 2002 Aug; 22(4):366-70. PubMed ID: 12172335
[TBL] [Abstract][Full Text] [Related]
9. [Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring].
Rao ML; Hiemke C; Grasmäder K; Baumann P;
Fortschr Neurol Psychiatr; 2001 Nov; 69(11):510-7. PubMed ID: 11704898
[TBL] [Abstract][Full Text] [Related]
10. Disposition of olanzapine in Chinese schizophrenic patients.
Lane HY; Liu HC; VanDenBerg CM; Su MH; Jann MW; Chang WH
Int J Clin Pharmacol Ther; 2000 Oct; 38(10):482-5. PubMed ID: 11073289
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue distribution of olanzapine in rats.
Aravagiri M; Teper Y; Marder SR
Biopharm Drug Dispos; 1999 Nov; 20(8):369-77. PubMed ID: 10870093
[TBL] [Abstract][Full Text] [Related]
12. The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
Markowitz JS; Devane CL; Liston HL; Boulton DW; Risch SC
Clin Pharmacol Ther; 2002 Jan; 71(1):30-8. PubMed ID: 11823755
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors.
Wu TH; Chiu CC; Shen WW; Lin FW; Wang LH; Chen HY; Lu ML
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1889-93. PubMed ID: 18796323
[TBL] [Abstract][Full Text] [Related]
14. Predicting drug interactions and pharmacokinetic variability with in vitro methods: the olanzapine experience.
Wrighton SA; Ring BJ
Drug Metab Rev; 1999 Feb; 31(1):15-28. PubMed ID: 10065363
[No Abstract] [Full Text] [Related]
15. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
[TBL] [Abstract][Full Text] [Related]
16. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism.
Lucas RA; Gilfillan DJ; Bergstrom RF
Eur J Clin Pharmacol; 1998 Oct; 54(8):639-43. PubMed ID: 9860152
[TBL] [Abstract][Full Text] [Related]
17. D2 receptor occupancy under recommended and high doses of olanzapine.
Harvey EJ; Taylor DM; Flanagan RJ
J Psychopharmacol; 2001 Sep; 15(3):213-4. PubMed ID: 11565632
[No Abstract] [Full Text] [Related]
18. Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia.
Chue P; Jones B; Taylor CC; Dickson R
Can J Psychiatry; 2002 Oct; 47(8):771-4. PubMed ID: 12420656
[TBL] [Abstract][Full Text] [Related]
19. Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia.
Reeves RR; Torres RA
South Med J; 2003 Jul; 96(7):699-701. PubMed ID: 12940325
[TBL] [Abstract][Full Text] [Related]
20. [Olanzapine. A new antipsychotic agent].
Bredkjoer SR; Gerlach J
Ugeskr Laeger; 1997 Nov; 159(48):7160-4. PubMed ID: 9417725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
